Related Experiment Video
Updated: Jul 4, 2026
04:20
Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
p19(ras) amplifies p73beta-induced apoptosis through mitochondrial pathway.
Jung-Woong Kim1, Won-Ho Kim, Mi-Hee Jeong
1Department of Life Science, College of Natural Sciences, Chung-Ang University, 221 Heuksuk Dong, Dongjak Ku, Seoul 156-756, Republic of Korea.
Biochemical and Biophysical Research Communications
|June 17, 2008
Summary
The protein p19(ras) enhances p73beta-induced apoptosis signaling, a process crucial for cellular damage responses. This interaction, amplified by Taxol, significantly increases apoptosis in cancer cells lacking p53.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- p73 and p53 are critical tumor suppressors involved in cellular damage responses like apoptosis.
- The precise mechanisms of p73-mediated apoptosis are less understood compared to p53.
- p73 is a structural and functional homolog of the p53 tumor suppressor gene.
Purpose of the Study:
- To elucidate the role of p19(ras) in modulating p73beta-induced apoptotic signaling pathways.
- To investigate the combined effects of p19(ras) and Taxol on apoptosis in cancer cells.
- To understand the functional interplay between p19(ras) and p73 in the context of cancer cell death.
Main Methods:
- Investigated the interaction between p19(ras) and p73beta.
- Assessed apoptotic signaling events, including Bax mitochondrial translocation and cytochrome c release.
- Measured reactive oxygen species (ROS) production and mitochondrial membrane potential (ΔΨm).
- Utilized Taxol treatment to modulate endogenous p19(ras) and p73beta expression and activity in p53-null SAOS2 cancer cells.
Main Results:
- p19(ras) interaction with p73beta amplifies apoptotic signaling, including Bax translocation, cytochrome c release, ROS production, and loss of mitochondrial potential.
- Taxol treatment significantly increases endogenous p19(ras) and p73beta expression.
- p19(ras) further amplifies Taxol-enhanced p73beta transcriptional activity, leading to marked apoptosis in p53-null cancer cells.
Conclusions:
- p19(ras) plays a significant role in amplifying p73beta-mediated apoptosis.
- The interplay between p19(ras) and p73beta is critical for Taxol-induced apoptosis in p53-deficient cancer cells.
- These findings provide insights into the molecular mechanisms of p19(ras)-p73 function in cancer therapy.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...